Short answer
GYRE THERAPEUTICS, INC. (GYRE) filed an 8-K current report with the SEC on May 12, 2026 reporting Item 7.01 (Regulation FD Disclosure). No substantive Regulation FD disclosure provided in the excerpt.
GYRE THERAPEUTICS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- No substantive Regulation FD disclosure provided in the excerpt
- Boilerplate exclusion prevents incorporation into other Exchange Act or Securities Act filings
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other GYRE THERAPEUTICS, INC. 8-K filings
Get the next GYRE 8-K as it lands
Follow GYRE for push alerts, or ask the research agent what this filing means.